Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ZFHX3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA563707
Description
Immunogen sequence: KAQVQVPQQS HQQILPQQQQ NQLSIAQSHS ALLQPSQHPE KKNKLVIKEK EKESQRERDS AEGGEGNTGP KETLPDA Highest antigen sequence identity to the following orthologs: Mouse - 83%, Rat - 76%.
Transcriptional repressor. It inhibits the enhancer element of the AFP gene by binding to its AT-rich core sequence. Regulator of myoblasts differentiation through the binding to the AT-rich sequence of MYF6 promoter and promoter repression. Down-regulates the MUC5AC promoter in gastric cancer. Miura Y., J. Biol. Chem. 270:26840-26848(1995). Morinaga T., Mol. Cell. Biol. 11:6041-6049(1991). Martin J., Nature 432:988-994(2004).
Specifications
ZFHX3 | |
Polyclonal | |
Unconjugated | |
ZFHX3 | |
A230102L03Rik; alpha-fetoprotein enhancer binding protein; alpha-fetoprotein enhancer-binding protein; AT motif binding factor 1; AT motif-binding factor 1; ATBF1; AT-binding transcription factor 1; ATBT; C16orf47; mKIAA4228; Putative uncharacterized protein C16orf47; RGD1560268; WBP9; ZFH-3; Zfhx3; zinc finger homeobox 3; zinc finger homeobox protein 3; Zinc finger homeodomain protein 3; ZNF927 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
463 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q15911 | |
ZFHX3 | |
Recombinant protein corresponding to Human ZFHX3. Recombinant protein control fragment (Product #RP-101926). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction